Primary Screening of Antioxidant Activity, Total Polyphenol Content, Carotenoid Content, and Nutritional Composition of 13 Edible Flowers from Japan.

Thirteen edible flowers, which are used as food ingredients in Japan, were evaluated as possible sources of antioxidants and biological compounds. The nutritional composition, total polyphenol content (TPC), carotenoid content, and antioxidant activity of the edible flowers were determined based on the oxygen radical absorbance capacity (ORAC). Water was the main constituent of edible flowers, and carbohydrates were the primary macronutrients. The TPC of the edible flowers varied from 1.47 to 13.08 mg gallic acid equivalent/g fresh weight (FW). Carotenoids, including ß-carotene and ß-cryptoxanthin, were detected mainly in the edible flowers with petal colors ranging from yellow to orange, but especially in primula and cosmos yellow flowers, which have yellow petals. The ORAC value of the hydrophilic extract (HORAC) of edible flowers was higher than the ORAC value of the lipophilic extract (LORAC). The total antioxidant capacity (TAC) ranged from 33.03 to 320.36 µM Trolox equivalent/g FW. The highest TPC and TAC were observed in cosmos yellow flowers. On the basis of Pearson's correlation coefficient, the HORAC value and the TPC of the analyzed edible flowers were highly correlated (r=0.736). This preliminary study indicates that edible flowers are a potential source of antioxidants, and the addition of edible flowers to the human diet may be associated with health benefits.

Experiences of Postcardiotomy Assist: Pneumatic Ventricular Assist Device or Venoarterial Bypass with Percutaneous Cardiopulmonary Support.

From October 1982 to the present, 16 patients have been supported by a pneumatic ventricular assist device (VAD). Since April 1990, we have introduced a venoarterial bypass (VAB) with percutaneous cardiopulmonary support (PCPS) system. This PCPS system was used in 12 patients. The long-term survival rate of PCPS cases (41%) was much better than that of VAD cases (19%). The main cause of death in VAD cases was multiple organ failure (MOF). Although VAB was initiated more recently than VAD, the duration on support was longer in the VAD group than in the VAB group. Because of the longer support duration and the presence of many patients with MOF, coagulopathy deteriorated more readily in the VAD group than in the VAB group. In the case of postcardiotomy cardiopulmonary bypass weaning or low-output syndrome (LOS), the VAB with PCPS system should be applied first under intraaortic balloon pumping assist because of its simplicity and low cost. Thereafter, VAD should be applied in cases refractory to VAB support.